The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions

The BioGRID (Biological General Repository for Interaction Datasets, thebiogrid.org) is an open‐access database resource that houses manually curated protein and genetic interactions from multiple species including yeast, worm, fly, mouse, and human. The ~1.93 million curated interactions in BioGRID can be used to build complex networks to facilitate biomedical discoveries, particularly as related to human health and disease. All BioGRID content is curated from primary experimental evidence in the biomedical literature, and includes both focused low‐throughput studies and large high‐throughput datasets. BioGRID also captures protein post‐translational modifications and protein or gene interactions with bioactive small molecules including many known drugs. A built‐in network visualization tool combines all annotations and allows users to generate network graphs of protein, genetic and chemical interactions. In addition to general curation across species, BioGRID undertakes themed curation projects in specific aspects of cellular regulation, for example the ubiquitin‐proteasome system, as well as specific disease areas, such as for the SARS‐CoV‐2 virus that causes COVID‐19 severe acute respiratory syndrome. A recent extension of BioGRID, named the Open Repository of CRISPR Screens (ORCS, orcs.thebiogrid.org), captures single mutant phenotypes and genetic interactions from published high throughput genome‐wide CRISPR/Cas9‐based genetic screens. BioGRID‐ORCS contains datasets for over 1,042 CRISPR screens carried out to date in human, mouse and fly cell lines. The biomedical research community can freely access all BioGRID data through the web interface, standardized file downloads, or via model organism databases and partner meta‐databases.

[1]  A. Tai,et al.  Dengue Virus Hijacks a Noncanonical Oxidoreductase Function of a Cellular Oligosaccharyltransferase Complex , 2017, mBio.

[2]  Darren J. Burgess CRISPR screens beyond Cas9 , 2020, Nature Reviews Genetics.

[3]  A. Belkina,et al.  BET domain co-regulators in obesity, inflammation and cancer , 2012, Nature Reviews Cancer.

[4]  Anna Campain,et al.  Discriminating lymphomas and reactive lymphadenopathy in lymph node biopsies by gene expression profiling , 2011, BMC Medical Genomics.

[5]  Boxun Lu,et al.  ATTEC: a potential new approach to target proteinopathies , 2020, Autophagy.

[6]  Kara Dolinski,et al.  The PhosphoGRID Saccharomyces cerevisiae protein phosphorylation site database: version 2.0 update , 2013, Database J. Biol. Databases Curation.

[7]  Kara Dolinski,et al.  The BioC-BioGRID corpus: full text articles annotated for curation of protein–protein and genetic interactions , 2017, Database J. Biol. Databases Curation.

[8]  W. John Wilbur,et al.  PIE the search: searching PubMed literature for protein interaction information , 2012, Bioinform..

[9]  Philipp M Cromm,et al.  Targeted Protein Degradation: from Chemical Biology to Drug Discovery. , 2017, Cell chemical biology.

[10]  Jürg Bähler,et al.  PomBase 2018: user-driven reimplementation of the fission yeast database provides rapid and intuitive access to diverse, interconnected information , 2018, Nucleic Acids Res..

[11]  T. Ideker,et al.  Comprehensive curation and analysis of global interaction networks in Saccharomyces cerevisiae , 2006, Journal of biology.

[12]  Brett Larsen,et al.  A SARS-CoV-2 – host proximity interactome , 2020, bioRxiv.

[13]  T. Akaike,et al.  AUTACs: Cargo-Specific Degraders Using Selective Autophagy. , 2019, Molecular cell.

[14]  Mike Tyers,et al.  BioGRID: a general repository for interaction datasets , 2005, Nucleic Acids Res..

[15]  Kara Dolinski,et al.  Proteome-wide, Structure-Based Prediction of Protein-Protein Interactions/New Molecular Interactions Viewer1[OPEN] , 2019, Plant Physiology.

[16]  Edith D. Wong,et al.  Saccharomyces Genome Database: the genomics resource of budding yeast , 2011, Nucleic Acids Res..

[17]  Gary D Bader,et al.  PSICQUIC and PSISCORE: accessing and scoring molecular interactions , 2011, Nature Methods.

[18]  Aditya Achanta,et al.  SnapShot: COVID-19 , 2020, Cell.

[19]  Shun Adachi,et al.  Toward Understanding Molecular Bases for Biological Diversification of Human Coronaviruses: Present Status and Future Perspectives , 2020, Frontiers in Microbiology.

[20]  Andrew R. Leach,et al.  The Global Phosphorylation Landscape of SARS-CoV-2 Infection , 2020, Cell.

[21]  Martin Hof,et al.  The C-terminal domain of Brd2 is important for chromatin interaction and regulation of transcription and alternative splicing , 2013, Molecular biology of the cell.

[22]  Isha H. Jain,et al.  Genetic Screen for Cell Fitness in High or Low Oxygen Highlights Mitochondrial and Lipid Metabolism , 2020, Cell.

[23]  Michael K. Gilson,et al.  BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology , 2015, Nucleic Acids Res..

[24]  Gos Micklem,et al.  esyN: Network Building, Sharing and Publishing , 2014, PloS one.

[25]  Roded Sharan,et al.  Using deep learning to model the hierarchical structure and function of a cell , 2018, Nature Methods.

[26]  Jennifer M. Rust,et al.  Selective Neuronal Vulnerability in Alzheimer’s Disease: A Network-Based Analysis , 2020, Neuron.

[27]  Xiaodong Huang,et al.  Drugging the undruggables: exploring the ubiquitin system for drug development , 2016, Cell Research.

[28]  Nevan J. Krogan,et al.  Functional genomic screens identify human host factors for SARS-CoV-2 and common cold coronaviruses , 2020, bioRxiv.

[29]  Max A. Horlbeck,et al.  Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification , 2016, Nature chemical biology.

[30]  Qingyu Chen,et al.  Overview of the BioCreative VI Precision Medicine Track: mining protein interactions and mutations for precision medicine , 2019, Database J. Biol. Databases Curation.

[31]  Haruki Nakamura,et al.  Protein Data Bank (PDB): The Single Global Macromolecular Structure Archive. , 2017, Methods in molecular biology.

[32]  David S H Bell Insulin therapy in diabetes mellitus: how can the currently available injectable insulins be most prudently and efficaciously utilised? , 2007, Drugs.

[33]  Mike Tyers,et al.  Imipridone Anticancer Compounds Ectopically Activate the ClpP Protease and Represent a New Scaffold for Antibiotic Development , 2020, Genetics.

[34]  M. Rapé,et al.  The Ubiquitin Code , 2012, Annual review of biochemistry.

[35]  Neville E. Sanjana,et al.  High-throughput functional genomics using CRISPR–Cas9 , 2015, Nature Reviews Genetics.

[36]  Eytan Ruppin,et al.  Discovery of SARS-CoV-2 Antivirals through Large-scale Drug Repositioning , 2020, Nature.

[37]  D. Falzarano,et al.  SARS and MERS: recent insights into emerging coronaviruses , 2016, Nature Reviews Microbiology.

[38]  John L. Rubinstein,et al.  Recognition of Semaphorin Proteins by P. sordellii Lethal Toxin Reveals Principles of Receptor Specificity in Clostridial Toxins , 2020, Cell.

[39]  Adam P. Rosebrock,et al.  A global genetic interaction network maps a wiring diagram of cellular function , 2016, Science.

[40]  Michael P Snyder,et al.  Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens , 2018, Nature Genetics.

[41]  Ralph S. Baric,et al.  The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses , 2020, Frontiers in Microbiology.

[42]  D. Botstein,et al.  Yeast: An Experimental Organism for 21st Century Biology , 2011, Genetics.

[43]  Steven J. M. Jones,et al.  Drug repositioning for personalized medicine , 2012, Genome Medicine.

[44]  Zhaohui S. Qin,et al.  A Global Protein Kinase and Phosphatase Interaction Network in Yeast , 2010, Science.

[45]  Jing Chen,et al.  NDEx, the Network Data Exchange. , 2015, Cell systems.

[46]  Kimberly Van Auken,et al.  WormBase: a modern Model Organism Information Resource , 2019, Nucleic Acids Res..

[47]  Tony Kouzarides,et al.  Targeting epigenetic readers in cancer. , 2012, The New England journal of medicine.

[48]  Zhiyong Lu,et al.  The Protein-Protein Interaction tasks of BioCreative III: classification/ranking of articles and linking bio-ontology concepts to full text , 2011, BMC Bioinformatics.

[49]  Tony Pawson,et al.  Signalling change: signal transduction through the decades , 2013, Nature Reviews Molecular Cell Biology.

[50]  Etienne Simon-Loriere,et al.  A Genome-Wide CRISPR-Cas9 Screen Identifies the Dolichol-Phosphate Mannose Synthase Complex as a Host Dependency Factor for Dengue Virus Infection , 2020, Journal of Virology.

[51]  Giulia Antonazzo,et al.  FlyBase 2.0: the next generation , 2018, Nucleic Acids Res..

[52]  Carolyn R. Bertozzi,et al.  Lysosome-targeting chimaeras for degradation of extracellular proteins , 2020, Nature.

[53]  Anne-Claude Gingras,et al.  Rare driver mutations in head and neck squamous cell carcinomas converge on NOTCH signaling , 2020, Science.

[54]  Georgios A. Pavlopoulos,et al.  Global BioID-based SARS-CoV-2 proteins proximal interactome unveils novel ties between viral polypeptides and host factors involved in multiple COVID19-associated mechanisms , 2020, bioRxiv.

[55]  Anushya Muruganujan,et al.  Alliance of Genome Resources Portal: unified model organism research platform , 2019, Nucleic Acids Res..

[56]  John G. Doench,et al.  Genome-wide CRISPR screen reveals host genes that regulate SARS-CoV-2 infection , 2020, bioRxiv.

[57]  David S. Wishart,et al.  DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..

[58]  Gang Wang,et al.  An overview of COVID-19 , 2020, Journal of Zhejiang University-SCIENCE B.

[59]  Pierre Thibault,et al.  The Coming of Age of Phosphoproteomics—from Large Data Sets to Inference of Protein Functions* , 2013, Molecular & Cellular Proteomics.

[60]  Kejiao Li,et al.  A Genetic Map of the Response to DNA Damage in Human Cells , 2019, Cell.

[61]  Gary D Bader,et al.  Biological Network Exploration with Cytoscape 3 , 2014, Current protocols in bioinformatics.

[62]  Benjamin J. Polacco,et al.  A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing , 2020, Nature.

[63]  Thomas L. Rothstein,et al.  Eμ-BRD2 transgenic mice develop B-cell lymphoma and leukemia , 2004 .

[64]  A. Lin,et al.  Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials , 2019, Science Translational Medicine.

[65]  Gregory J. Hannon,et al.  A CRISPR Resource for Individual, Combinatorial, or Multiplexed Gene Knockout , 2017, Molecular cell.

[66]  David C. Smith,et al.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.

[67]  Kara Dolinski,et al.  The BioGRID interaction database: 2019 update , 2018, Nucleic Acids Res..

[68]  Jennifer A. Doudna,et al.  CRISPR-CasΦ from huge phages is a hypercompact genome editor , 2020, Science.

[69]  Jamie Waese,et al.  The Bio-Analytic Resource for Plant Biology. , 2017, Methods in molecular biology.

[70]  Neville E. Sanjana,et al.  Massively parallel Cas13 screens reveal principles for guide RNA design , 2020, Nature Biotechnology.

[71]  Tony Pawson,et al.  Modular evolution of phosphorylation-based signalling systems , 2012, Philosophical Transactions of the Royal Society B: Biological Sciences.

[72]  Neville E Sanjana,et al.  Genome-scale CRISPR pooled screens. , 2017, Analytical biochemistry.

[73]  Robert D Cardiff,et al.  E mu-BRD2 transgenic mice develop B-cell lymphoma and leukemia. , 2004, Blood.